Anicure Formulations Profile
Key Indicators
- Authorised Capital ₹ 0.20 M
as on 16-12-2024
- Paid Up Capital ₹ 0.10 M
as on 16-12-2024
- Company Age 16 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.57 M
as on 16-12-2024
About Anicure Formulations
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.20 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹3.57 M.
Syed Fatah and Neelam Hashmi serve as directors at the Company.
- CIN/LLPIN
U24232UP2008PTC036148
- Company No.
036148
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Oct 2008
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Bareilly, Uttar Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Anicure Formulations Private Limited offer?
Anicure Formulations Private Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Vitamin & Multivitamin Injections, Animal Feed Supplement, Veterinary Medicines, Veterinary Drugs, Antacid Drugs, Allopathic Liver Tonic, Cattle Feed Supplement, Animal Medicines & Health Care, Veterinary Bolus.
Who are the key members and board of directors at Anicure Formulations?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Syed Fatah  | Director | 14-Oct-2008 | Current |
| Neelam Hashmi | Director | 27-Dec-2009 | Current |
Financial Performance of Anicure Formulations.
Anicure Formulations Private Limited, for the financial year ended 2016, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Anicure Formulations?
In 2017, Anicure Formulations had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Idbi Bank Limited Creation Date: 21 Feb 2018 | ₹3.57 M | Open |
How Many Employees Work at Anicure Formulations?
Unlock and access historical data on people associated with Anicure Formulations, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Anicure Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Anicure Formulations's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
